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Summary: We describe an on-line multi-cplumn high performance liquid Chromatographie method for the
selective clean-up and analysis of major and minor ribonucleosides in physiological fluids. Quantitative data
obtained for the determination of some methylated ribonucleosides in human urines are compared with those
obtained with the traditional off-line method.
The on-line technique developed in our laboratory is distinguished from the off-line method by the following
features:
(1) Sample clean-up and analysis of the target-compounds can easily be automatized,
(2) Total time of analysis, for example of urinary ribonucleosides, is decreased to 35 minutes,
(3) Laborious and error-prone evaporation and redissolution Steps are avoided,
(4) Reliability of the overall analytical System can be controlled with ease,
(5) Small sample-volumes can be applied directly,
(6) Sensitive samples can be processed very rapidly under mild conditions,
(7) Results obtained with the -line and off-line-techniques compare well.
Entwicklung einer chromatographischen Methode zur quantitativen Bestimmung seltener Ribonucleoside in
physiologischen Flüssigkeiten
Charakterisierung und quantitative Bestimmung von seltenen Ribonucleosiden in physiologischen Flüssig-
keiten, Teil I
Zusammenfassung: Wir beschreiben ein <iQn-line"-Mehrsäulen-hQchIeistungsflüssig-chromatographisches
Verfahren zur selektiven Aufreinigung und Analyse häufiger und seltener Ribonucleoside in physiologischen
Flüssigkeiten. Die für die quantitative Bestimmung einiger methylierter Ribonucleoside in Humanharnen
erhaltenen Ergebnisse werden mit denen eines traditionellen "off-line"-Verfahrens verglichen.
Im Vergleich zum off-line Verfahren zeichnet sich die von uns entwickelte "on-line"-Technik durch folgende
Eigenschaften aus:
(1) Probenaufreinigung und Analyse der Zielsubstanzen lassen sich leicht automatisieren,
(2) Die Gesamtanalysendauer, z.B. für harngängige Ribonucleoside verkürzt sich auf 35 Minuten,
(3) Aufwendige und fehlerträchtige Konzentrierungs- und Wiederaufnahmeschritte entfallen,
(4) Die Zuverlässigkeit des gesamten analytischen Systems kann mühelos kontrolliert werden,
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(5) Kleine Probenvolumina können direkt appliziert werden,
(6) Empfindliche Proben können in kürzester Zeit unter schonenden Bedingungen analysiert werden,
(7) Die mit der "on-line" wie mit der "off-line"-Technik erhaltenen Ergebnisse zeigen eine gute Überein^
Stimmung.
Introduction
The measurement of major and minor (modified)
nucleosides (fig. 1) in biological fluids, such äs urine
or serum or in hydrolysates of RNA and DNA, has
become of potential interest in molecular biology
and clinical biochemistry. As constituents of mRNA,
rRNA and especially of tRNA, modified nucleosides
play a significant role in protein synthesis äs well äs
in many other regulatory processes (l, 2). After
breakdown of RNA the modified nucleosides, in
contrast to major nucleosides, do not enter the sal-
vage pathways (3) but are excreted almost entirely in
urine (4, 5); they are thus powerful indicators of pa-
thobiochemical processes, e.g. tumour growth (6),
adenosine deaminase deficiency and severe com-
bined immunodeficiency (7, 8) or lack of hypoxan-
thine/guanine phosphoribosyltransferase activity
(Lesh-Nyhan syndrome) (3).
Taking into account that more than 50 modified nu-
cleosides have been isolated and characterized in
tRNA (9) and more than 30 in urine (10) the neces-
sity for the development of a sensitive and efficient
analytical method becomes obvious.
Whereas in recent years much effort has been put
into the improvement of resolution, sensitivity of de-
tection and reliatbility of the Chromatographie System
in nucleoside analysis (11-13), the techniques for
sample preparation, höwever, have not kept pace
with these developments.
Boronate gel affinity chrömatography for the clean
up of ribonucleosides in biological fluids, introduced
in 1976 by Uziel, Smith & Taylor (14) and optimized
by Davis and co-workers (15), still presents the gen-
erally preferred technique for the clean^up of ribo-


























Fig. 1. Ribonucleosides investigated.
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Encouraged by the publication of a boronic acid-
functionalized silica (22), which is particular suitable
for HPLC, we attempted to transfer the commonly
used urinary clean-up procedure from Iow pressure
column chromatography to HPLC conditions thus
applying a method known s high-performance liq-
uid (ligand) affinity chromatography (HPLAC) (23).
As the material described was not suitable for this
purpose we developed a new boronate silica which
fulfilled the conditions required (24). By coupling
the HPLAC System, developed in our laboratory, to
reversed-phase HPLC (RP-HPLC) by a column
switching technique, we finally evolved a Chromato-
graphie System for the on-line clean-up and analysis
of ribonucleosides in physiological fluids (25, 26).
In the present paper this on-line method is compared
with the traditional off-line procedure.
Experimental
Mater i a l s and Methods
Chemicals
Nl-methyladenosine (ir^Ado), Nl-methylinosine (m!Ino), Nl-
methylguanosine (m'Guo), N2-methylguanosine (m2Guo), N6-
dimethyladenosine (mjAdo), N6-methyladenosine (m6 Ado),
pseudouridine (Ψ) were purchased from Sigma, M nchen. Aden-
osine (Ado), inosine (Ino), guanosine (Guo), uridine (Urd) and
cytidine (Cyd) were from Boehringer, Mannheim. N2-dimethyl-
guanosine (m?Guo) and N6-(carbamoyl-threonyl)-adenosine
(t6Ado) were isolated from urine and characterized by UV-,
mass- and ^-NMR-spectroscopy s well s by characteristic
chemical reactions; for further characterization t6Ado was chemi-
cally synthesized in parallel (27).
In all buffer preparations double distilled water and salts of purest
grade available were used. Organic solvents were of LiChrosolv
quality (Merck, Darmstadt).
Synthesis of affinity Supports
Boronic acid-functionalized polyacrylamide was synthesized by
coupling Hydrazide-Bio-Gel P-2 (200^400 mesh, hydrazide ca-
pacity 2.4 mmol/1 per dry gram, Βίο-Rad, M nchen) with succinic
anhydride and m-^aminobenzeneboronic acid (Sigma) according to
I.e. (14, 15).
For synthesis of boronic acid-functionalized silica LiChrosorb Si
100, 5 μπι, (Merck) was substituted with γ-chloropropyltrime-
thoxysilane (generous gift from Dynamit Nobel, Troisdorf) and
subsequently reacted with m^aminobenzene'boronic acid accord-
ing to 1. c. (24). Meanwhile a boronic acid substituted silica of
comparable quality is commercially available from Serva Feinbio-
chemica, Heidelberg s "Dihydroxyboryl-Polyol Si 100", 5 μπι.
HPLC apparatus
The basic HPLC equipment consisted of two Altex Model 110 A
pumps (Altex, USA) controlled by a Model 420 microprocessor, a
Rheodyne Model 7125 loop injector for sample introduction and
a Kontron Uvicon Model 725 spectrophotometer (Kontron,
Eching) for monitoring the UV-absorbance of the effluent at
259 nm. Areas under the peaks obtained were integrated with a
Hewlett Packard Model 3390 A integrator (Hewlett-Packard,
Frankfurt).
For on-line analysis this basic gradicnt System was additionally
equipped with a third Altex Model 110 A pump, a second Rheo-
dyne 7125 loop injector and a Rheodyne Model 7010 six-port
valve, which were incorporated s shown schematically in scheme
I (top),
Sample collection and storage
24 h urine specimens were stored at 0-5 °C with sodium azide s
preservative until collection was completcd. After collection,
20 ml portions were adjusted to pH 4 with 850 g/kg formic acid
and stored at -20°C.
Fresh blood samples were centrifuged at 2000g for 10 minutes at
4 °C. Serum was collected, adjusted to pH 4 with 850/kg formic
acid and subsequently stored at -20 °C or immediately processed.
A n a l y t i c a l procedure
Off-line method
1) Sample preparation
For analysis, 1.5 ml of urine was mixed with 150 μΐ of 2.5 mol/1
ammonium acetate pH 8.8 and, if necessary, with 100—200 μΐ 2
mol/l sodium hydroxide to obtain a slightly alkaline pH (pH 8).
Urine samples were then membrane filtered (Millox 0.22 μητι,
Millipore, France) and immediately applied to the affinity gel co-
lumn. *
Human serum (1.5 ml) was deproteinized within 40 min by cen-
trifugal Ultrafiltration (Amicon, Micropartition System) at 5000g
and 4 °C. After pH adjustment, l ml of serum ultrafiltrate was
applied to the affinity gel column.
2) Clean-up of ribonucleosides on boronic acid-substituted affin-
ity gel
The selective group Separation of ribonucleosides in urine or se-
rum ultrafiltrate was achieved by ligand affinity chromatography
using a glass column (50 x 5 mm I.D.) filled with boronic acid-
functionalized Bio-Gel P-2. Elution was carried out with a Model
Minipuls II pump (Gilson, France). The effluent was monitored
continuously with an ISCO Model UA 5 absorbance detector (In-
strumentation Specialties, USA) at 254 nm. The affinity gel co-
lumn was equilibrated at pH 8.8 with 0.25 mol/1 ammonium ace-
tate. The sample (l ml of pretreated urine, serum ultrafiltrate or
synthetic nucleoside mixture) was transferred to the top of the
boronate gel column, which was then eluted successively with
(A) 0.25 mol/1 ammonium acetate pH 8.8 (fraction 1),
(B) H2 (fraction 2) and
(C) 0.1 mol/1 formic acid (fraction 3).
Fractions 2 and 3 were shell frozen, lyophilized and redissolved in
2 x 500 μΐ of H2O. Aliquots were then analysed by HPLC.
3) HPLC determination of nucleosides
The column used for RP-HPLC of fraction 2 was a stainless steel
column, 125 x 4 mm I.D., packed in the laboratory with Nucleo-
sil® 5C18 (Macherey & Nagel, D ren). Cation-exchange chroma-
tography of fraction 3 was run on an Altex Partisil SCX column,
ΙΟμπι (250 x 3.2 mm I.D.).




Human -urine (500 μΐ) was membrane filtered (Millox 0.22 μη\)
and an aliquot of 50 μΐ was applied to the HPLAC-column. Sam-
ples of human serum (250 μΐ) were deproteinized within 10 min
by centrifugal ultrafiltration at 5000g and 4°C. The appropriatc
ultrafiltrate (50 μΐ) was applied to the HPLAC-column.
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2) On-Iine clean-up and analysis of ribonucleosides in urine and
serum
For the on-line analysis of ribonucleosides in urine or serum the
HPLAC-column l (30 x 4 mm I.D., filled with boronic acid-sub-
stituted silica) was equilibrated for 2 min in valve position "Load"
with 0.1 mol/1 ammonium phosphate pH 8.3. After sample injec-
tion column l was washed with the same buffer for 2 min. During
that time ribonucleosides were selectively retarded on the
HPLAC-column whereas the sample matrix was discharged.
After this clean-up Step the valve was switched to "Inject" and
thereby series-connected in front of column 2 (250 x 4 mm I.D.,
filled with LiChrosorb RP 18,7 , Merck). The group specifical-
ly bound ribonucleosides on column l were theii eluted under
acidic conditions (0.15 mol/1 ammonium formale pH 3.5) in a
small volume through positions 2-1-4-3 of the valve (Compare
scheme I) and concentrated on top of column 2 over a period of
1.5 min. This elution buffer was also used for the subsequent ana-
lytical Separation. The valve was then switched back into position
"Load" and elution of column 2 could be carried out independ^
ently by increasing the amount of organic modifier in the mobile











Top: On-line System setup
Bottom: Valve switching positions.
Quant i ta t ive determinat ions
Calibration mixtures for quantitative evaluätion of the nucleoside
peaks obtained by HPLC were prepared by dissolving 2 mg of the
appropriate nucleoside in l ml of double distilled water or, in the
case of m1 Ado, in 0.1 mol/1 formic acid. As some nucleosides do
not dissolve entirely, the Solutions were centrifuged at 2000 g for
2 min and the supernatants transferred to testrtubes. The nucleo-
side concentration in the supernatant was then determined spec-
trophotometrically (Zeiss PMQ 3). The final concentration was
calculated äs the mean of three independent analyses. For calibra-
tion of the Chromatographie System according to the "External
Standard Method" calibration mixtures containing 200 to 400
pmol each of the appropriate nucleosides were analysed and abso-
lute molar factors for each nucleoside were determined by the
integrator äs the mean value of at least four independent funs.
Calibration was checked daily and recalibration was carried out if
the calculated amounts for the calibration mixture differed more
than 5% from the Standard values.
Resiilts and Discussion
Off-line clean-üp and analysis of ribonu-
cleosides in physiological fluids
Affinity chromatography of ribonucleosides on bo-
ronic acid-functionalized polyacrylamide gel
Boronic äcid is known to form complexes generally
with 1,2 cis-diol bearing compounds äs present in the
ribose moiety of nucleosides, varigus carbohydrates
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Fig. 2! Boronic acid affinity chromatography based on ,pH-shift.
O O~TH O-f°H = SUDStances withoutLOH' LOH and with cis-Siiol groups
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The target molecules selectively bound on the boro-
nate gel are eluted by lowering the buffer salt con-
centration or decreasing the pH of the mobile phase
- both being conditions which lead to a destabiliza-
tion of the boronate-cis-diol complex (29). By app-
lying this two Step gradient elution we could achieve
a prefractionation of urinary and serum ribonucleo-
sides in which ''neutral9' nucleosides such s Ino,
Guo, Ado, n^Ino, m2Guo etc. are eluted with HzO;
whereas the cationic ones, for example m1 Ado and
m7Guo, elute with formic acid (cf. fig. 3).
Fractions 2 and 3 were lyophilized, redissolved in







Fig. 3. Typical elution profiles from a boronic acid affinity gel co-
lumn.
The samples of
a) l .0 ml pretreated (cf. Analytical procedure, Off-line
method, Sample preparation) urine or
b) 1.0ml serum ultrafiltrate were eluted with
(A) 0.25mol/l ammonium acetate pH 8.8 (fraction 1),
(B) H2O (fraction 2) and
(C) 0.1 mol/1 formic acid (fraction 3).
Fraction l consists of non retarded substances, fraction 2
and 3 contain the neutral and cationic ribonucleosides, re-
spectively.
HPLC-analysis of ribonucle side fractions
Fraction 2 obtained in the clean-up procedure was
analysed by RP-HPLC. A detailed description of pa-
rameters affecting the Separation f major and modi-
fied nucleosides in the reversed-phase mode of
HPLC is given in 1. c. (12).
Figure 4 shows in a) the Separation of a synthetic
mixture of 11 naturally occurring ribonucleosides; in
b) the Separation of a 100 μΐ aliquot of a "water"











Fig. 4. Reversed-phase HPLC Separation of ribonucleosides in
physiological fluids.
a) Separation of a synthetic mixture (100 μΐ; 2-10 nmol
of each nucleoside). The peak numbering refers to fig-
ure 1.
b) Separation of a ΙΟΟμΙ aliquot of a "water fraction"
obtained in the liquid Chromatographie prefractiona-
tion step of urine (cf. Results and Discussion, Off-line
clean-up, ..., Affinity chromatography ...). The nu-
cleosides 8, 10, 12 were quantitatively investigated.
c) Separation of a 100 μΐ aliquot of a "water fraction"
obtained by the prefractionation procedure of a serum
sample. Prior to prefractionation the sample was con-
centrated 20-fold.
Chromatographie conditions: Nucleosil® 5 C 18 (125 x
4 mm I.D.), buffer: 0.2 mol/1 ammonium formate pH 3.5;
elution: 0-5 min isocratically with methanol-free buffer,
5—11 min with buffer/methanol (96 + 4 by volume), after
11 min a gradient was run up to buffer/methanol (70 + 30
by volume) in 18min; flow rate: 1.3 ml/min; detection:
259 nm.
Although peak 7 (retention time identical with Ado)
and peak 9 (retention time identical with m1 Guo)
appear s single peaks, it could be demonstrated by
Variation of the pH or ionic strength of the mobile
phase that these compounds coelute with at least one
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or two other UV-absorbing cis-diol bearing com-
pounds. As no satisfactory resolution could be
achieved continuously, peaks 7 and 9 were not consi-
dered for quantitative investigations. Peaks 8, 10
and 12 were characterized äs rn^no (8), m2Guo (10)
and miGuo (12) by comparison of retention times of
authentic synthetic nucleosides and co-chromatogra-
phy of authentic nucleosides in a spiked control
urine. To prove homogeneity of the Chromatograph-
ie zone, peaks 8, 10 and 12 were frequently pooled
during the analyses of "water"fractions and addi-
tionally characterized by UV-, mass- and ^-spec-
troscopy äs well äs specific chemical reactions (27).
Figure 4c shows the RP-HPLC Separation of a "wa-
ter "fraction obtained in the clean-up of human se-
rum ultrafiltrate. Ino (5), Guo (6) and Ado (7) could
be characterized äs main components by enzymatic
peak shift and quench, respectively.
The quantitative determination of these major nu-
cleosides in serum samples, however, is difficult be-
cause enzyme activities are present in native serum.
Thus, for example, adenosine is quantitatively deam-
inated to inosine within 3 h after venipuncture. In-
osine, on the other hand, is converted to hypoxan-
thine, although at a slower rate (11).
By adjusting serum to pH 4 immediately after cen-
trifugation we were able to suppress enzyme activi-
ties so that adenosine, guanosine and inosine could
be characterized at least qualitatively (30). The mi-
nor ribonucleosides in human serum still present
analytical difficulties äs they are present only in very
small amounts. Preliminary results indicate m1 Ino,
m2Guo and m2Guo concentrations of about 100
nmol of each nucleoside per liter of human serum
(31).
The "acidic" fraction (fraction 3; urine) was ana-
lysed by ion-exchange HPLC äs outlined in 1. c. (17).
The main component of this fraction was character-
ized äs m1 Ado, accompanied by small amounts of
m7Guo. The identity of mlAdo was confirmed by
characteristic chemical reactions and Chromato-
graphie properties (17, 32) and further considered in
our quantitative investigations (33).
Accuracy andprecision ofurinary ribonudeoside de-
termination
The reliability for the off-line procedure has beert
frequently proved (14-16). Matrix-dependent and
-independent analyses of the nucleosides investigat-
ed gave recoveries > 90% (Average Standard devia-
tions for the determination of m1 Ado, n^Ino,
m2Guo and mlGuo are given in table 3).
On-line clean-up and analysis of ribonu-
cleosides in physiological f luids
On-line analysis
With the development of a HPLAC-column (24) the
aforementioned low pressure liquid ehromatography
(LAG) technique can now be performed ander high
pressure conditions. Under acidic conditions, the ri-
bonucleosides investigated elute from the HPLAC-
column in a small volüme (approx. 700 ), This al-
lows a column switching technique, i.e., the direct
transfer of this zone to a reversed-phase column. In
addition, most nucleosides are conceiiträted on top
of the RP-Cis column due to their hydrophobic char-
acter. After this tränsfer-step, RP-HPLC can be nm
independently and elution of ribonucleosides can be
carried out by increasing the amoüiit of organic mo-
difier in the mobile phase (fig. 5).
A comparison of the RP-HPLC run (fig. 5a) and the
on-line procedure (fig. 5b) shows that the latter does
not affect bandbfoadening and resolution of the nu-
cleosides investigated. This result is in good ägree-
ment with the findings of Gehrke et al. (12) who
demonstrated that sample volumes üp to l ml do not
essentially influence theoretical plate height and res-
olution of nucleosides on a RP-Cis column.
The method described allows the direct analysis of
ribonucleosides in native urine or deproteinized se-
rum within 33 min with a detection limit of l of
the appropriate nucleoside per liter biological fluid.
Accuracy andprecision ofurinary ribonudeoside de-
termination
1) Linearity
Figure 6 shows the excellent linearity between sam-
ple volüme analysed and amount of nucleoside
found. Linearity was proved for the determination of
m1 Ado, m^no, m2Guo and m2Guo in 20 to 100 of
native urine. Between 100 and 2500 pmol of the ap-
propriate nucleoside could be measured with corre-
lation coefficients for linear regression between
0.994 and 1.003. The wide linear ränge is sufficient
for routine determination and analysis of nucleosides
in physiological fluids.
2) Analytical recoyery of nucleosides
To monitor the aecuracy of the overall, Chromato-
graphie System, the matrix^dependent and -inde-
pendent recovery of nucleosides was determined.
For jnatrix-independent recovery a synthetic rnix-
ture of nucleosides (4, 8,10,12) was applied directly
to the RP^column (compare ScheMe I) or analysed
J. Clin. Chem. Clin. Biochem. / Vol. 22, 1984 / No. 2
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Fig. 5. HPLAC/Reversed-phase HPLC Separation of ribonu-
cleosides.
a) Off-Iine (HPLC) chromatogram of 14 synthetic major
and minor riboriucleosides (100 μΐ; 2—10 nmol of each
nucleoside).
b) On-line (HPLAC-HPLC) ehromatography of a 100 μΐ
sample of the same nucleoside mixture s above.
c) On-line ehromatography of a urine sample (50 μΐ).
d) On-line ehromatography of a serum ultfafiltrate
(50 μΐ).
The elution of column l in the on-line system is described
in detail in section Analytical procedure, On-line-method,
On-line clean up ...
Chromatographie conditions for column 2: Li Chrosorb
RP 18, 7 μιη (250 x 4mm I.D.); elution: 0.15 mol/1 am-
monium formate pH 3.5; after 2 min a linear gradient was
run up to ammonium formate/methanol (92 4- 8 by vo-
lume) in 10 min followed by a linear gradient up to ammo-
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Fig. 6. Linearity of on-line HPLAC/RP-HPLC anaJysis of
m'Ado, m'lno, m2Guo and mjGuo.
mjGuo (Δ-Δ), r = 1.003; m1 Ado (D-D), r = 0.999;
m1 Ino (Π-Π), r = 0.994; m2Guo (O-O), r = 0.999.
by the on-line HPLAC/RP-HPLC System. For ma-
trix-dependent recovery the amount of nucleoside
present in a control urine was determined by the Ex-
ternal Standard Method. The control urine was then
spiked with defined amounts of nucleosides and ana-
lysed anew. Results are summarized in tables l and
2.














a Each value is an average of tljree runs
b Relative Standard deviation
Tab. 2. Matrix-dependent recovery of nucleosides added to
pooled control urine.
Nucleoside Concentration3 (μπιοΐ/ΐ)



















a Each value is an average of three runs
b Standard deviation
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Off - l ine /on- l ine comparison
Figure 7 representatively shows the good correlation
of results obtained by both the off-line and on-line
method for the determination of m1 Ado in 25 differ-
ent urines (values for n^Ino, m2Guo and miGuo are
given in legend to figure 7).
Whereas the regression line for m1 Ado nearly corre-
sponds with the bisector of the angle indicating high
concurrence of the results obtained by both meth-
ods, the regression lines for π^Ιηο (δ), m2Guo (10)
and m^Guo (12) show a slightly lower slope. This
may partly be explained by the fact that the on-line
method gave better analytical recovery of nucleo-
sides than the off-line method.
Generally both methods turn out to be appropriate
for the determination of ribonucleosides in physio-
logical fluids. Figure 8, however, illustrates the con-
siderable advantages of the on-line method.
(1) Total time f analysis is tremendously shor-
tened. Sample clean-up, including time-consuming
evaporation steps, is no longer a time limiting factor
and is decreased from 145 to 2min.
(2) Small sample volumes can be analysed. As far s
human serum is concerned only 150 to 250 μΐ of na-
10 20 30 40
m1 Ado ( n-line) fyimol/24 h]
Fig. 7. Off-line/one-line correlation.
The comparison of the "off-line" and "on-line"-chroma-
tography methods is based on the quantitative determina-
tion of m1 Ado, n^Ino, m2Guo and mjGuo in 20 different
urines and representatively shown for nf^AdOi
Each value is an average of three independent runs. Re-
gression lines:
m1 Ado, y = 1.003 χ + 0.006, r = 0.9633;
m'lno, y = 0.894x4- 2.132, r = 0.9185;
m2Guo, y = 0.642 χ + 1.515, r= 0.6988;
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Application of 1.0ml
on ff ini ty gel column
Elution
Evaporation
Redissolution in 1000 ̂ l











injection of 5θμ on HPLAC precolumn
30
Σ 47 Σ 33
Fig. 8. Flow diagram.
The comparison of the off-line and the on-line method shows in detail the working Steps and the time advantage eained by the on-line System. ; -. β ·β - ^
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tive serum must be deproteinized by ultracentrifuga-
tion for determination of major nucleosides, i.e. this
procedure reduces sample processing costs.
(3) Sensitive samples, e. g. human serum can be pro-
cessed very rapidly.
(4) Small sample volumes, for example micropunc-
tuates or RNA-hydrolysates, can be directly applied
and analysed.
(5) The apparatus allows easy automatization by
use of an automatic sample processor and a pneu-
matic switching valve (compare Scheme I).
(6) The analytical procedure can be easily con-
trolled for its reliability.
(7) Error-prone evaporation- and redissolution
steps are avoided, thus leading to an improvement of
the analytical precision. Table 3 shows the average
coefficient of Variation (%) for the determination of
mJAdo, m^no, m2Guo and miGuo in 25 different
urines.
Conclusions
The on-lirie HPLAC/RP-HPLC method described
in this paper is compared with the conventional off-
line LAC/RP-HPLC procedure which was applied
by us for the quantitative determination of n^Ado,
m1Ino,m2Guo and miGuo in urines of pregnant and
Tab. 3. Average relative Standard deviation (CV, %) for the de-















a Relative Standard deviation. Each of the 25 urine values was
determined three times.
non-pregnant females (33). The results obtained by
both methods show good concurrence and correla-
tion. Since the occurrence of nucleosides in physio-
logical fluids turned out to be predicative for the di-
agnosis of pathobiochemical processes, the on-line
System is the method of choice, äs it is particularly
suitable for automatization and applicable for rou-
tine clinical analysis. As affinity chromatography on
boronic acid-functionalized polymers is also well
known for the pre-purification of catecholamines in
physiological fluids (34—38), for the Separation of
ribonucleosides and ribonucleotides from the corre-
sponding deoxy-compounds (22, 39,40), the Separa-
tion of RNA from DNA (41, 42) and the Separation
of queuine-containing tRNA from non-queuine
tRNA (41) or aminoacyl-tRNA from uncharged
tRNA (41, 42) the use of boronate HPLAC in com-
bination with the presented column switching tech-
nique offers a wide ränge of application.
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